These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 27470509

  • 1. Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.
    Lu H, Howatt DA, Balakrishnan A, Graham MJ, Mullick AE, Daugherty A.
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1753-7. PubMed ID: 27470509
    [Abstract] [Full Text] [Related]

  • 2. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
    Roche-Molina M, Sanz-Rosa D, Cruz FM, García-Prieto J, López S, Abia R, Muriana FJ, Fuster V, Ibáñez B, Bernal JA.
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
    [Abstract] [Full Text] [Related]

  • 3. Expression of a PCSK9 Gain-of-Function Mutation in C57BL/6J Mice to Facilitate Angiotensin II-Induced AAAs.
    Sawada H, Daugherty A, Lu HS.
    Biomolecules; 2022 Jun 29; 12(7):. PubMed ID: 35883473
    [Abstract] [Full Text] [Related]

  • 4. Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
    Liu J, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Sorci-Thomas M, Cassis LA, Daugherty A.
    Arterioscler Thromb Vasc Biol; 2015 Aug 29; 35(8):1826-34. PubMed ID: 26044581
    [Abstract] [Full Text] [Related]

  • 5. Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.
    Wang S, Subramanian V, Lu H, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A.
    Atherosclerosis; 2012 Feb 29; 220(2):375-80. PubMed ID: 22153700
    [Abstract] [Full Text] [Related]

  • 6. Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.
    Howatt DA, Balakrishnan A, Moorleghen JJ, Muniappan L, Rateri DL, Uchida HA, Takano J, Saido TC, Chishti AH, Baud L, Subramanian V.
    Arterioscler Thromb Vasc Biol; 2016 May 29; 36(5):835-45. PubMed ID: 26966280
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
    Jarrett KE, Lee C, De Giorgi M, Hurley A, Gillard BK, Doerfler AM, Li A, Pownall HJ, Bao G, Lagor WR.
    Arterioscler Thromb Vasc Biol; 2018 Sep 29; 38(9):1997-2006. PubMed ID: 30026278
    [Abstract] [Full Text] [Related]

  • 10. AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.
    Somanathan S, Jacobs F, Wang Q, Hanlon AL, Wilson JM, Rader DJ.
    Circ Res; 2014 Aug 29; 115(6):591-9. PubMed ID: 25023731
    [Abstract] [Full Text] [Related]

  • 11. Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Subramanian V, Uchida HA, Ijaz T, Moorleghen JJ, Howatt DA, Balakrishnan A.
    J Cardiovasc Pharmacol; 2012 Jan 29; 59(1):66-76. PubMed ID: 21964156
    [Abstract] [Full Text] [Related]

  • 12. Sex Chromosome Complement Defines Diffuse Versus Focal Angiotensin II-Induced Aortic Pathology.
    Alsiraj Y, Thatcher SE, Blalock E, Fleenor B, Daugherty A, Cassis LA.
    Arterioscler Thromb Vasc Biol; 2018 Jan 29; 38(1):143-153. PubMed ID: 29097367
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms.
    Thatcher SE, Zhang X, Howatt DA, Yiannikouris F, Gurley SB, Ennis T, Curci JA, Daugherty A, Cassis LA.
    Arterioscler Thromb Vasc Biol; 2014 Dec 29; 34(12):2617-23. PubMed ID: 25301841
    [Abstract] [Full Text] [Related]

  • 14. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
    Cansby E, Magnusson E, Nuñez-Durán E, Amrutkar M, Pedrelli M, Parini P, Hoffmann J, Ståhlman M, Howell BW, Marschall HU, Borén J, Mahlapuu M.
    Arterioscler Thromb Vasc Biol; 2018 Aug 29; 38(8):1723-1737. PubMed ID: 29930001
    [Abstract] [Full Text] [Related]

  • 15. Angiotensinogen Exerts Effects Independent of Angiotensin II.
    Lu H, Wu C, Howatt DA, Balakrishnan A, Moorleghen JJ, Chen X, Zhao M, Graham MJ, Mullick AE, Crooke RM, Feldman DL, Cassis LA, Vander Kooi CW, Daugherty A.
    Arterioscler Thromb Vasc Biol; 2016 Feb 29; 36(2):256-65. PubMed ID: 26681751
    [Abstract] [Full Text] [Related]

  • 16. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.
    Denis M, Marcinkiewicz J, Zaid A, Gauthier D, Poirier S, Lazure C, Seidah NG, Prat A.
    Circulation; 2012 Feb 21; 125(7):894-901. PubMed ID: 22261195
    [Abstract] [Full Text] [Related]

  • 17. A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Xu M, Wu X, Liu Z, Ding Y, Kong W, Little PJ, Xu S, Weng J.
    Biochem Biophys Res Commun; 2022 Sep 24; 622():163-169. PubMed ID: 35868060
    [Abstract] [Full Text] [Related]

  • 18. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9.
    Seidah NG, Abifadel M, Prost S, Boileau C, Prat A.
    Pharmacol Rev; 2017 Jan 24; 69(1):33-52. PubMed ID: 27920219
    [Abstract] [Full Text] [Related]

  • 19. Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.
    Vozenilek AE, Vetkoetter M, Green JM, Shen X, Traylor JG, Klein RL, Orr AW, Woolard MD, Krzywanski DM.
    J Vasc Res; 2018 Jan 24; 55(2):98-110. PubMed ID: 29455203
    [Abstract] [Full Text] [Related]

  • 20. Dennd5b-Deficient Mice are Resistant to PCSK9-Induced Hypercholesterolemia and Diet-Induced Hepatic Steatosis.
    Mobilia M, Whitus C, Karakashian A, Lu HS, Daugherty A, Gordon SM.
    J Lipid Res; 2022 Dec 24; 63(12):100296. PubMed ID: 36243100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.